Review



flow cytometry based il 22 secretion assay detection kit pe  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Miltenyi Biotec flow cytometry based il 22 secretion assay detection kit pe
    Flow Cytometry Based Il 22 Secretion Assay Detection Kit Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+22+secretion+assay/IL-22+Secretion+Assay+-+Detection+Kit+(PE)%2C+human/pm40983704-340-12-18
    Average 99 stars, based on 1 article reviews
    flow cytometry based il 22 secretion assay detection kit pe - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Magnetic Cell Separation:

    Article Title: Human skin is colonized by T cells that recognize CD1a independently of lipid
    Article Snippet: .. The IL-22 secretion assay (MACS Miltenyi) was used with skin T cells restimulated by overnight coculture with K562-CD1a (2:1) in T cell media with 4% human AB serum. ..

    Article Title: Human skin is colonized by T cells that recognize CD1a independently of lipid
    Article Snippet: .. The IL-22 secretion assay (MACS Miltenyi) was used with skin T cells restimulated by overnight coculture with K562CD1a (2:1) in T cell media with 4% human AB serum. ..



    Similar Products

    99
    Miltenyi Biotec flow cytometry based il 22 secretion assay detection kit pe
    Flow Cytometry Based Il 22 Secretion Assay Detection Kit Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+22+secretion+assay/IL-22+Secretion+Assay+-+Detection+Kit+(PE)%2C+human/pm40983704-340-12-18
    Average 99 stars, based on 1 article reviews
    flow cytometry based il 22 secretion assay detection kit pe - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    93
    R&D Systems il 22 secretion
    Il 22 Secretion, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+22+secretion+assay/Human+IL-22+DuoSet+ELISA/pm38149947-89-8-13
    Average 93 stars, based on 1 article reviews
    il 22 secretion - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    99
    Miltenyi Biotec il 22 secretion assay
    Il 22 Secretion Assay, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+22+secretion+assay/IL-22+Secretion+Assay+-+Detection+Kit+(PE)%2C+human/pmc07773353-582-1-5
    Average 99 stars, based on 1 article reviews
    il 22 secretion assay - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Miltenyi Biotec il-22-specific secretion assay
    EPs® 7630 <t>stimulates</t> <t>IL-22</t> and IL-17 secretion of human PBMCs. a Human PBMCs were stimulated in a kinetic approach with 3 μg/ml EPs® 7630, 100 ng/ml LPS, or were left untreated as indicated. b Dose-response analysis was performed by treatment of human PBMCs with increasing concentrations (0–3 μg/ml, as indicated) of EPs® 7630 for 48 h. Quantification of IL-22, IL-17, and IFN-γ in culture supernatants was performed by ELISA. Data from 3 ( a ) or 12 ( b ) independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05; ** p < 0.01, Wilcoxon matched-pairs signed-rank test)
    Il 22 Specific Secretion Assay, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+22+secretion+assay/il22+secretion/pmc07524690-58-7-10
    Average 90 stars, based on 1 article reviews
    il-22-specific secretion assay - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Anhui Medical University p-77 (id-86) il-22 secreting cd4+ t cells
    EPs® 7630 <t>stimulates</t> <t>IL-22</t> and IL-17 secretion of human PBMCs. a Human PBMCs were stimulated in a kinetic approach with 3 μg/ml EPs® 7630, 100 ng/ml LPS, or were left untreated as indicated. b Dose-response analysis was performed by treatment of human PBMCs with increasing concentrations (0–3 μg/ml, as indicated) of EPs® 7630 for 48 h. Quantification of IL-22, IL-17, and IFN-γ in culture supernatants was performed by ELISA. Data from 3 ( a ) or 12 ( b ) independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05; ** p < 0.01, Wilcoxon matched-pairs signed-rank test)
    P 77 (Id 86) Il 22 Secreting Cd4+ T Cells, supplied by Anhui Medical University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+22+secretion+assay/p+77++id+86++il+22+secreting+cd4++t+cells/pm28075209-1054-4-64
    Average 90 stars, based on 1 article reviews
    p-77 (id-86) il-22 secreting cd4+ t cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    EPs® 7630 stimulates IL-22 and IL-17 secretion of human PBMCs. a Human PBMCs were stimulated in a kinetic approach with 3 μg/ml EPs® 7630, 100 ng/ml LPS, or were left untreated as indicated. b Dose-response analysis was performed by treatment of human PBMCs with increasing concentrations (0–3 μg/ml, as indicated) of EPs® 7630 for 48 h. Quantification of IL-22, IL-17, and IFN-γ in culture supernatants was performed by ELISA. Data from 3 ( a ) or 12 ( b ) independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05; ** p < 0.01, Wilcoxon matched-pairs signed-rank test)

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

    doi: 10.1007/s00109-020-01970-3

    Figure Lengend Snippet: EPs® 7630 stimulates IL-22 and IL-17 secretion of human PBMCs. a Human PBMCs were stimulated in a kinetic approach with 3 μg/ml EPs® 7630, 100 ng/ml LPS, or were left untreated as indicated. b Dose-response analysis was performed by treatment of human PBMCs with increasing concentrations (0–3 μg/ml, as indicated) of EPs® 7630 for 48 h. Quantification of IL-22, IL-17, and IFN-γ in culture supernatants was performed by ELISA. Data from 3 ( a ) or 12 ( b ) independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05; ** p < 0.01, Wilcoxon matched-pairs signed-rank test)

    Article Snippet: To characterize EPs® 7630–dependent IL-22 producers, an IL-22-specific secretion assay (Miltenyi Biotec) was performed using PBMCs according to the manufacturer’s protocol.

    Techniques: Enzyme-linked Immunosorbent Assay

    EPs® 7630 pretreatment modulates the cytokine production of activated lymphocytes. a , b Human PBMCs were pretreated with different concentrations of EPs® 7630 as indicated for 24 h. Afterwards, activators of T cells (anti-CD3/anti-CD28 Abs) ( a ) and innate lymphoid cells (cytokine mixture composed of IL-1β, IL-2, and IL-12) ( b ) were added for further 24 h. Quantification of IL-17, IL-22 and IFN-γ in culture supernatants was performed by ELISA. Data from 12 donors per group are given as mean ± SEM. Significant differences are indicated (* p < 0.05; ** p < 0.01, Wilcoxon matched-pairs signed-rank test)

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

    doi: 10.1007/s00109-020-01970-3

    Figure Lengend Snippet: EPs® 7630 pretreatment modulates the cytokine production of activated lymphocytes. a , b Human PBMCs were pretreated with different concentrations of EPs® 7630 as indicated for 24 h. Afterwards, activators of T cells (anti-CD3/anti-CD28 Abs) ( a ) and innate lymphoid cells (cytokine mixture composed of IL-1β, IL-2, and IL-12) ( b ) were added for further 24 h. Quantification of IL-17, IL-22 and IFN-γ in culture supernatants was performed by ELISA. Data from 12 donors per group are given as mean ± SEM. Significant differences are indicated (* p < 0.05; ** p < 0.01, Wilcoxon matched-pairs signed-rank test)

    Article Snippet: To characterize EPs® 7630–dependent IL-22 producers, an IL-22-specific secretion assay (Miltenyi Biotec) was performed using PBMCs according to the manufacturer’s protocol.

    Techniques: Enzyme-linked Immunosorbent Assay

    IL-22 strengthens the antibacterial defense of airway epithelial cells. a A549 human lung epithelial cells were cultured in the presence or absence (control) of IL-22, its inhibitor IL-22BP, or a combination of IL-22 and IL-22BP for 48 h. b BALB/c mice were i.p. injected with PBS (control) or IL-22. At the indicated time points after injection, mice were sacrificed and lung tissue was taken for analysis of S100A9 expression by RT-qPCR. Data of 4 (0 h control and PBS) or 3 (IL-22) mice per group are given as mean ± SEM. c A549 human lung epithelial cells were pretreated or not with 3 μg/ml EPs® 7630 for 24 h followed by stimulation with IL-22, IL-17A, IFN-γ, or the combination of IL-17A and IL-22 for 48 h or were left unstimulated (control). a , c Expression of S100A9, LCN2, and MX1 was analyzed by RT-qPCR. Data of 7 ( a ) or 3–4 ( c ) independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05, Wilcoxon matched-pairs signed-rank test)

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

    doi: 10.1007/s00109-020-01970-3

    Figure Lengend Snippet: IL-22 strengthens the antibacterial defense of airway epithelial cells. a A549 human lung epithelial cells were cultured in the presence or absence (control) of IL-22, its inhibitor IL-22BP, or a combination of IL-22 and IL-22BP for 48 h. b BALB/c mice were i.p. injected with PBS (control) or IL-22. At the indicated time points after injection, mice were sacrificed and lung tissue was taken for analysis of S100A9 expression by RT-qPCR. Data of 4 (0 h control and PBS) or 3 (IL-22) mice per group are given as mean ± SEM. c A549 human lung epithelial cells were pretreated or not with 3 μg/ml EPs® 7630 for 24 h followed by stimulation with IL-22, IL-17A, IFN-γ, or the combination of IL-17A and IL-22 for 48 h or were left unstimulated (control). a , c Expression of S100A9, LCN2, and MX1 was analyzed by RT-qPCR. Data of 7 ( a ) or 3–4 ( c ) independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05, Wilcoxon matched-pairs signed-rank test)

    Article Snippet: To characterize EPs® 7630–dependent IL-22 producers, an IL-22-specific secretion assay (Miltenyi Biotec) was performed using PBMCs according to the manufacturer’s protocol.

    Techniques: Cell Culture, Injection, Expressing, Quantitative RT-PCR

    CD4 + memory T cells are no direct targets of EPs® 7630. a CD4 + memory T cells were isolated from human PBMCs by magnetic labeling–based cell sorting and cultured for 48 h in the absence (control) or presence of EPs® 7630 (0–10 μg/ml) as indicated. b CD4 + memory T cells were stimulated as described in a and were further activated after 24 h of culture by anti-CD3/CD28 antibodies (Dynabeads) for another 24 h. a , b Culture supernatants were analyzed for IL-22, IL-17, and IFN-γ level by ELISA. Data from 5 independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05, Wilcoxon matched-pairs signed-rank test)

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

    doi: 10.1007/s00109-020-01970-3

    Figure Lengend Snippet: CD4 + memory T cells are no direct targets of EPs® 7630. a CD4 + memory T cells were isolated from human PBMCs by magnetic labeling–based cell sorting and cultured for 48 h in the absence (control) or presence of EPs® 7630 (0–10 μg/ml) as indicated. b CD4 + memory T cells were stimulated as described in a and were further activated after 24 h of culture by anti-CD3/CD28 antibodies (Dynabeads) for another 24 h. a , b Culture supernatants were analyzed for IL-22, IL-17, and IFN-γ level by ELISA. Data from 5 independent experiments are given as mean ± SEM. Significant differences among treatment groups are indicated (* p < 0.05, Wilcoxon matched-pairs signed-rank test)

    Article Snippet: To characterize EPs® 7630–dependent IL-22 producers, an IL-22-specific secretion assay (Miltenyi Biotec) was performed using PBMCs according to the manufacturer’s protocol.

    Techniques: Isolation, Labeling, FACS, Cell Culture, Enzyme-linked Immunosorbent Assay

    Monocytes play a key role in EPs® 7630–induced IL-22 production by T cells. a CD4 + memory T cells and autologous monocytes were co-cultured or cultured alone for 72 h in the absence (control) or presence of 10 μg/ml EPs® 7630 (EPs® 7630). b CD4 + memory T cells and autologous monocytes were pretreated in separate cultures with EPs® 7630 (10 μg/ml) or medium with solvent for 24 h. Afterwards, CD4 + memory T cells and monocytes were washed and co-cultured as indicated for 72 h without further EPs® 7630 stimulation. c CD4 + memory T cells were cultured for 72 h in the presence of supernatant (SN) obtained from cultures of EPs® 7630–stimulated (10 μg/ml) monocytes. d CD4 + memory T cells and autologous monocytes were co-cultured with (no transwell) or without enabled cell-cell contact (transwell) or were cultured separately for 72 h in the presence of 10 μg/ml EPs® 7630. a – d Human CD4 + memory T cells and autologous monocytes were each isolated by magnetic labeling–based cell sorting. Quantification of IL-22 in culture supernatants was carried out by ELISA. e Human PBMCs were stimulated or not (solvent control) in a kinetic approach with 10 μg/ml EPs® 7630 or 100 ng/ml LPS or were left without stimulation up to 72 h. Quantification of IL-1β, IL-23, and IL-2 levels in culture supernatant was performed by ELISA. f Human PBMCs were stimulated or not (solvent control) with 3 μg/ml EPs® 7630, in the presence of 1.5 μg/ml IL-1RA, 3 μg/ml anti-IL-23p19 antibody, or a combination thereof for 72 h. Quantification of IL-22 in culture supernatants was carried out by ELISA. Data from 6 ( a ), 2 ( b ), 4 ( c ), 5 ( d ) 3–4 ( e ), and 5 ( f ) independent experiments are given as mean ± SEM. Significant differences between treatment groups are indicated (* p < 0.05, Wilcoxon matched-pairs signed-rank test). Tmem: CD4 + memory T cells; mo: monocytes

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

    doi: 10.1007/s00109-020-01970-3

    Figure Lengend Snippet: Monocytes play a key role in EPs® 7630–induced IL-22 production by T cells. a CD4 + memory T cells and autologous monocytes were co-cultured or cultured alone for 72 h in the absence (control) or presence of 10 μg/ml EPs® 7630 (EPs® 7630). b CD4 + memory T cells and autologous monocytes were pretreated in separate cultures with EPs® 7630 (10 μg/ml) or medium with solvent for 24 h. Afterwards, CD4 + memory T cells and monocytes were washed and co-cultured as indicated for 72 h without further EPs® 7630 stimulation. c CD4 + memory T cells were cultured for 72 h in the presence of supernatant (SN) obtained from cultures of EPs® 7630–stimulated (10 μg/ml) monocytes. d CD4 + memory T cells and autologous monocytes were co-cultured with (no transwell) or without enabled cell-cell contact (transwell) or were cultured separately for 72 h in the presence of 10 μg/ml EPs® 7630. a – d Human CD4 + memory T cells and autologous monocytes were each isolated by magnetic labeling–based cell sorting. Quantification of IL-22 in culture supernatants was carried out by ELISA. e Human PBMCs were stimulated or not (solvent control) in a kinetic approach with 10 μg/ml EPs® 7630 or 100 ng/ml LPS or were left without stimulation up to 72 h. Quantification of IL-1β, IL-23, and IL-2 levels in culture supernatant was performed by ELISA. f Human PBMCs were stimulated or not (solvent control) with 3 μg/ml EPs® 7630, in the presence of 1.5 μg/ml IL-1RA, 3 μg/ml anti-IL-23p19 antibody, or a combination thereof for 72 h. Quantification of IL-22 in culture supernatants was carried out by ELISA. Data from 6 ( a ), 2 ( b ), 4 ( c ), 5 ( d ) 3–4 ( e ), and 5 ( f ) independent experiments are given as mean ± SEM. Significant differences between treatment groups are indicated (* p < 0.05, Wilcoxon matched-pairs signed-rank test). Tmem: CD4 + memory T cells; mo: monocytes

    Article Snippet: To characterize EPs® 7630–dependent IL-22 producers, an IL-22-specific secretion assay (Miltenyi Biotec) was performed using PBMCs according to the manufacturer’s protocol.

    Techniques: Cell Culture, Solvent, Isolation, Labeling, FACS, Enzyme-linked Immunosorbent Assay

    EPs® 7630 induces IL-22 secretion by different CD4 + memory T cell subsets. a – c Human PBMCs were stimulated or not (solvent control) with 10 μg/ml EPs® 7630 for 72 h as indicated. Afterwards, an IL-22-specific secretion assay and surface marker staining was performed followed by flow cytometry–based analysis. a Schematic overview of the experimental setting of IL-22-specific secretion assay. b Data from one representative out of three independent experiments are given. c Data from 3 independent experiments are given as mean ± SEM

    Journal: Journal of Molecular Medicine (Berlin, Germany)

    Article Title: The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

    doi: 10.1007/s00109-020-01970-3

    Figure Lengend Snippet: EPs® 7630 induces IL-22 secretion by different CD4 + memory T cell subsets. a – c Human PBMCs were stimulated or not (solvent control) with 10 μg/ml EPs® 7630 for 72 h as indicated. Afterwards, an IL-22-specific secretion assay and surface marker staining was performed followed by flow cytometry–based analysis. a Schematic overview of the experimental setting of IL-22-specific secretion assay. b Data from one representative out of three independent experiments are given. c Data from 3 independent experiments are given as mean ± SEM

    Article Snippet: To characterize EPs® 7630–dependent IL-22 producers, an IL-22-specific secretion assay (Miltenyi Biotec) was performed using PBMCs according to the manufacturer’s protocol.

    Techniques: Solvent, Marker, Staining, Flow Cytometry